Two Sigma Investments’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.7K | Sell |
17,386
-23,764
| -58% | -$39.2K | ﹤0.01% | 3052 |
|
|
2025
Q1 | $54.7K | Buy |
41,150
+10,809
| +36% | +$14.4K | ﹤0.01% | 2974 |
|
|
2024
Q4 | $56.7K | Buy |
+30,341
| New | +$56.7K | ﹤0.01% | 2966 |
|
|
2024
Q1 | – | Sell |
-13,184
| Closed | -$13.8K | – | 3231 |
|
|
2023
Q4 | $13.8K | Sell |
13,184
-6,461
| -33% | -$6.78K | ﹤0.01% | 2976 |
|
|
2023
Q3 | $22K | Sell |
19,645
-49,884
| -72% | -$55.9K | ﹤0.01% | 2788 |
|
|
2023
Q2 | $105K | Sell |
69,529
-57,557
| -45% | -$86.6K | ﹤0.01% | 2673 |
|
|
2023
Q1 | $198K | Sell |
127,086
-340,198
| -73% | -$531K | ﹤0.01% | 2482 |
|
|
2022
Q4 | $298K | Sell |
467,284
-30,245
| -6% | -$19.3K | ﹤0.01% | 2191 |
|
|
2022
Q3 | $662K | Sell |
497,529
-12,818
| -3% | -$17.1K | ﹤0.01% | 1600 |
|
|
2022
Q2 | $1.13M | Buy |
510,347
+34,068
| +7% | +$75.6K | ﹤0.01% | 1439 |
|
|
2022
Q1 | $2.95M | Sell |
476,279
-121,197
| -20% | -$750K | 0.01% | 1144 |
|
|
2021
Q4 | $7.54M | Buy |
597,476
+524,401
| +718% | +$6.62M | 0.02% | 747 |
|
|
2021
Q3 | $6.7M | Buy |
73,075
+36,928
| +102% | +$3.38M | 0.02% | 758 |
|
|
2021
Q2 | $1.92M | Sell |
36,147
-1,464
| -4% | -$77.6K | ﹤0.01% | 1354 |
|
|
2021
Q1 | $1.36M | Buy |
37,611
+17,311
| +85% | +$624K | ﹤0.01% | 1460 |
|
|
2020
Q4 | $564K | Buy |
20,300
+7,758
| +62% | +$216K | ﹤0.01% | 1549 |
|
|
2020
Q3 | $627K | Buy |
12,542
+1,723
| +16% | +$86.1K | ﹤0.01% | 1332 |
|
|
2020
Q2 | $501K | Buy |
+10,819
| New | +$501K | ﹤0.01% | 1422 |
|